Literature DB >> 29129060

Alternate Reductants with VB12 to Transform C8 and C6 Perfluoroalkyl Sulfonates: Limitations and Insights into Isomer-Specific Transformation Rates, Products and Pathways.

Saerom Park1, Chloe de Perre1, Linda S Lee1.   

Abstract

Previous studies evaluating Vitamin B12 (VB12) with Ti(III)-citrate for potential use in in situ remediation of perfluorooctanesulfonate (PFOS) found that linear (L)-PFOS was unaltered. We explored if alternate reductants could overcome this limitation with a primary focus on nanoscale zerovalent zinc (nZn0). Transformation over time with VB12-nZn0 was quantified at 22, 70, and 90 °C for PFOS, at 70 °C for perfluorohexanesulfonate (PFHxS), and VB12-nFe0 and VB12-Pd0/nFe0 at 70 °C for PFOS. Only branched (br-) isomers were transformed generating F- (no SO42-) and polyfluoroalkyl intermediates/products. The absence of L-PFOS transformation by VB12 appears to be due to the inability of L-perfluoroalkyl sulfonates to complex with VB12 and not an activation energy issue that can be overcome by stronger reductants/catalysts. At 90 °C, 95% of br-PFOS isomers were transformed within 5 days. Isomer-specific removal rates were positively correlated to the br-CF3's proximity to the terminal CF3. Br-PFHxS transformation was approximately two times slower with less defluorination than br-PFOS. C8/C7 and C6/C5 polyfluorinated sulfonates from br-PFOS and br-PFHxS, respectively, were identified as both intermediates and apparent dead-end products. Pathways included 4 F replaced by 2 H and a C═C bond, and serial F replacement by H with up to 12 F atoms removed from br-PFOS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29129060     DOI: 10.1021/acs.est.7b03744

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  1 in total

1.  Evaluating perfluorooctanesulfonate oxidation in permanganate systems.

Authors:  Saerom Park; Linda S Lee; Ian Ross; Jake Hurst
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-08       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.